Study to Investigate DRP-104 in Adults With Advanced Solid Tumors

Clinical trial NCT04471415 · TERMINATED

Trial details

NCT number: NCT04471415
Sponsor: Dracen Pharmaceuticals, Inc.
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Solid Tumor Non Small Cell Lung Cancer Metastatic

Start date: 2020-08-31
Primary completion: 2023-03-28
Enrollment: 61

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.